These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 19386025)

  • 21. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effective analysis of transjugular intrahepatic portosystemic shunt versus surgical portacaval shunt for variceal bleeding in early cirrhosis.
    Pierce DS; Sperry J; Nirula R
    Am Surg; 2011 Feb; 77(2):169-73. PubMed ID: 21337874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis.
    Perarnau JM; Baju A; D'alteroche L; Viguier J; Ayoub J
    Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1093-8. PubMed ID: 20308910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis.
    Van Ha TG; Hodge J; Funaki B; Lorenz J; Rosenblum J; Straus C; Leef J
    Cardiovasc Intervent Radiol; 2006; 29(5):785-90. PubMed ID: 16850140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial.
    Perarnau JM; Le Gouge A; Nicolas C; d'Alteroche L; Borentain P; Saliba F; Minello A; Anty R; Chagneau-Derrode C; Bernard PH; Abergel A; Ollivier-Hourmand I; Gournay J; Ayoub J; Gaborit C; Rusch E; Giraudeau B;
    J Hepatol; 2014 May; 60(5):962-8. PubMed ID: 24480619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-stage transjugular intrahepatic porta-systemic shunt for patients with cirrhosis and a high risk of portal-systemic encephalopathy patients as a bridge to orthotopic liver transplantation: a preliminary report.
    Wróblewski T; Rowiński O; Ziarkiewicz-Wróblewska B; Górnicka B; Albrecht J; Jones EA; Krawczyk M
    Transplant Proc; 2006; 38(1):204-8. PubMed ID: 16504703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical application of the transjugular intrahepatic portosystemic stent-shunt in the emergency treatment of esophagogastric varices bleeding due to cirrhosis].
    You LY; Li YC; Yan D; Xu Y; Yang J; Yang LH; Cheng F; Yang JH
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):490-3. PubMed ID: 22152237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term effects of transjugular intrahepatic shunt on cardiac function assessed by cardiac MRI: preliminary results.
    Kovács A; Schepke M; Heller J; Schild HH; Flacke S
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):290-6. PubMed ID: 19730936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
    Kim JJ; Dasika NL; Yu E; Fontana RJ
    J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of TIPS in patients with hemophilia and cirrhosis.
    Beirne JP; Bloom AI; Bass NM; Kerlan RK; Wilson MW; Gordon RL; Laberge JM
    J Vasc Interv Radiol; 2007 Feb; 18(2):309-12. PubMed ID: 17327567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.).
    Merli M; Salerno F; Riggio O; de Franchis R; Fiaccadori F; Meddi P; Primignani M; Pedretti G; Maggi A; Capocaccia L; Lovaria A; Ugolotti U; Salvatori F; Bezzi M; Rossi P
    Hepatology; 1998 Jan; 27(1):48-53. PubMed ID: 9425916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transjugular intrahepatic portosystemic shunt versus open splenectomy and esophagogastric devascularization for portal hypertension with recurrent variceal bleeding.
    Su AP; Zhang ZD; Tian BL; Zhu JQ
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):169-175. PubMed ID: 28381381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of transjugular intrahepatic portosystemic shunt in the management of bleeding ectopic varices in cirrhotic patients.
    Vidal V; Joly L; Perreault P; Bouchard L; Lafortune M; Pomier-Layrargues G
    Cardiovasc Intervent Radiol; 2006; 29(2):216-9. PubMed ID: 16284702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].
    Han GH; Meng XJ; Yin ZX; Wang JH; He CY; Liang J; Guo XG; Liu J; Ding L; Wu KC; Fan DM
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1549-52. PubMed ID: 19953883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
    Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
    Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
    Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
    Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transjugular intrahepatic portosystemic shunt versus distal splenorenal shunt--a comparative study.
    Khaitiyar JS; Luthra SK; Prasad N; Ratnakar N; Daruwala DK
    Hepatogastroenterology; 2000; 47(32):492-7. PubMed ID: 10791220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding.
    Mahadeva S; Bellamy MC; Kessel D; Davies MH; Millson CE
    Am J Gastroenterol; 2003 Dec; 98(12):2688-93. PubMed ID: 14687818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
    Nair S; Singh R; Yoselewitz M
    J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.